Cleared Traditional

K913562 - QMS - DIGOXIN

K913562 is an FDA 510(k) clearance for QMS - DIGOXIN, manufactured by Seradyn, Inc.. The device is a Class 2 Chemistry device with product code LCS cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K913562 · Seradyn, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1991
Decision
21d
Days
Class 2
Risk

K913562 is an FDA 510(k) clearance for the QMS - DIGOXIN. Classified as Radioimmunoassay, Digoxin (125-i) (product code LCS), Class II - Special Controls.

Submitted by Seradyn, Inc. (Indianapolis, US). The FDA issued a Cleared decision on August 30, 1991 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3320 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Seradyn, Inc. devices

FDA 510(k) Submission Details - K913562

510(k) Number K913562 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 1991
Decision Date August 30, 1991
Days to Decision 21 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 88d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LCS Device Classification - Class 2, Special Controls

Product Code LCS Radioimmunoassay, Digoxin (125-i)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - LCS Radioimmunoassay, Digoxin (125-i)

All 11
Devices cleared under the same product code (LCS) and FDA review panel - the closest regulatory comparables to K913562.
DIGOXIN COATED TUBE RIA
K922353 · Monobind · Aug 1992
INNOFLUOR DIGOXIN REAGENT SET
K895828 · Innotron of Oregon, Inc. · Oct 1989
FIAGEN DIGOXIN TIME-RESOLVED FLUOROIMMUNOASSAY KIT
K884707 · Cyberfluor, Inc. · Jan 1989
IMMPULSE DIGOXIN ASSAY REAGENTS
K874748 · Sclavo, Inc. · Feb 1988
DART DIGOXIN ASSAY
K864802 · Coulter Electronics, Inc. · Feb 1987
TDX DIGOXIN
K820154 · Abbott Laboratories · Feb 1982